Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Nig. J. Basic Appl. Sci.. 2016; 24(2): 23-30
doi: 206122


Dislipidaemia in HIV-1 Infected Subjects with Short Term Usage of Highly Active Antiretroviral Therapy (HAART) in Benin City, Nigeria

Osaretin Godwin Igharo, Humphrey B. Osadolor, Theophilus L Olawoye and Festus Aigbokheo Idomeh.




Abstract

Background: One of the reasonable goals for HIV chemotherapy is to get the most effective drugs with minimal or negligible side effects in the long run.

Aim: This study was designed to investigate the short term effects of stavudine, lamivudine and nevirapine on serum lipids of HIV-1 positive subjects in Benin City, Nigeria, between three and six months of usage.

Methods: Test group 1 (n=78) and test group 2 (n= 71) comprised HIV- 1 seropositive individuals on HAART for a period of one to three months; and five to six months respectively. Fifty five newly diagnosed HIV-1 positive subjects naïve to HAART served as control group 1 and sixty apparently healthy HIV-1 seronegative individuals served as control group 2. The blood samples obtained were analyzed for total cholesterol, triglycerides, low density lipoprotein and high density lipoprotein using standard enzymatic methods.

Results: Mean total cholesterol concentration of test group 2 (214.0±6.43mg/dL) was not significantly different from Test group 1 (202.4±5.09mg/dL), both were however significantly higher than control group 1 (159.3±5.09mg/dL) and control group 2 (101.6±3.76 mg/dL); p

Key words: Dislipidaemia, HIV chemotherapy (HAART), Lipid profile, HIV






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.